Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2007
12/13/2007US20070287175 Sirna That Inhibits Wt1 Gene Expression And Uses Thereof
12/13/2007US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders
12/13/2007US20070287163 Methods for Diagnosis of Acute Myeloid Leukemia
12/13/2007US20070286906 Dihydrobenzoquinone compounds
12/13/2007US20070286905 Method for the Preparation of Trans-or Cis-Diammoniumdichlorodihydroxoplatinum(IV) and the Use Thereof in the Production of Pharmaceutical Active Substances
12/13/2007US20070286897 Liposomal Formulations of Anthracycline Agents and Cytidine Analogs
12/13/2007US20070286867 Combination Therapy
12/13/2007US20070286862 Cancer Associated Antigens
12/13/2007US20070286861 Therapeutic antibody specific for oncostatin M for use in treatment and diagnosis of rheumatoid arthritis, juvenile onset arthritis or osteoarthritis
12/13/2007US20070286860 Compositions and Methods for Inducing Anti-Tumor Immunity
12/13/2007US20070286856 Enzyme is a drug target; cancer, inflammatory diseases such as psoriasis
12/13/2007US20070286854 Diagnostics And Therapeutics For Diseases Associated With Dipeptidyl-Peptidase 1 (Dpp1)
12/13/2007US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard)
12/13/2007US20070286851 Method of Identifying Modulators of NOGO-Functions
12/13/2007US20070286845 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
12/13/2007US20070286843 Recombinant Polypeptides of the Members of the Tnf Ligand Family and Use Thereof
12/13/2007DE202004021321U1 Verwendung eines Extraktes von Aloysia triphylla Use of an extract of Aloysia triphylla
12/13/2007DE19529057B4 Ifosfamid-Lyophilisat-Zubereitungen Ifosfamide lyophilized preparations
12/13/2007DE102006027156A1 New sulfimide compounds are protein kinase inhibitors useful to treat e.g. cancer, Hodgkin's lymphoma, Kaposi's sarcoma, cardiovascular disease, Crohn's disease, endometriosis and hemangioma
12/13/2007DE102004040014B4 Aureonitrile, Verfahren zu ihrer Herstellung und ihre Verwendung Aureonitrile, processes for their preparation and their use
12/13/2007CA2771971A1 Gene involved in immortalization of human cancer cell and use thereof
12/13/2007CA2657947A1 Fkbp-l and uses thereof
12/13/2007CA2657946A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease
12/13/2007CA2654978A1 Gene involved in immortalization of human cancer cell and use thereof
12/13/2007CA2654572A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
12/13/2007CA2654457A1 Fermented milk product and use thereof
12/13/2007CA2654318A1 Sulphimides as protein kinase inhibitors
12/13/2007CA2654025A1 Hepatocyte growth factor (hgf) binding proteins
12/13/2007CA2654019A1 Hepatocyte growth factor (hgf) binding proteins
12/13/2007CA2653527A1 New salts and crystalline salt forms of an indolinone derivative
12/13/2007CA2653424A1 Novel indazole derivative having spiro ring structure in side chain
12/13/2007CA2653237A1 Use of vascular endothelial growth factor receptor inhibitors for the treatment of cancer
12/12/2007EP1865319A1 Method of testing whether a tumor is susceptible to treatment with a ginkgo biloba extract or Ginkgolide B by testing whether the cancer is characterized by an over-expression of peripheral-type benzodiazepine receptor protein
12/12/2007EP1865065A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
12/12/2007EP1865058A1 Anti-cd-20 monoclonal antibody
12/12/2007EP1865055A1 Component of bromelain
12/12/2007EP1864997A1 ROR ALPHA PROMOTING THE INDUCTION OF Bmal1 EXPRESSION
12/12/2007EP1864992A2 Monosaccharide derivatives
12/12/2007EP1864986A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof
12/12/2007EP1864983A1 Pyrimidine compounds as cyclin-dependent kinase inhibitors
12/12/2007EP1864977A1 Novel cyclic compound having pyrimidinylalkylthio group
12/12/2007EP1864976A1 Propane-1,3-dion derivative or salt thereof
12/12/2007EP1864975A2 Novel compounds
12/12/2007EP1864974A1 Potentiator for radiation therapy comprising pyridine derivative as active ingredient
12/12/2007EP1864972A1 Bcrp/abcg2 inhibitor
12/12/2007EP1864691A1 Modified CEA nucleic acid and expression vectors
12/12/2007EP1864683A1 Radiotherapy enhancer
12/12/2007EP1864682A1 Leptomycin derivatives
12/12/2007EP1864673A2 Method for producing an anti-cancer agent
12/12/2007EP1864660A2 Medical compositions for intravesical treatment of bladder cancer
12/12/2007EP1864659A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
12/12/2007EP1864643A1 Oil/fat-containing composition for suppression of cancer development
12/12/2007EP1864131A2 Natural ligand of g protein coupled receptor rcc356 and uses thereof
12/12/2007EP1863906A1 Use of a combination of myxoma virus and rapamycin for therapeutic treatment
12/12/2007EP1863814A1 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
12/12/2007EP1863811A1 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
12/12/2007EP1863810A1 NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1' RECEPTOR LIGANDS
12/12/2007EP1863809A2 Pyrazolopyridines and analogs thereof
12/12/2007EP1863807A1 'n-(2-chloro-6-methylphenyl)-2-ýý6-ý4-(2-hydroxyethyl)-1-piperazinyl¨-2-methyl-4-pyrimidinyl¨amino¨-5-thiazolecarboxamides metabolites
12/12/2007EP1863805A1 Pyrimidine compounds having tie2 (tek) inhibitory activity
12/12/2007EP1863797A1 2-AZETIDINYL-4-(lH-PYRAZOL-3-YLAMINO)PYRIMIDINES AS INHIBITORS OF INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ACTIVITY
12/12/2007EP1863792A1 Atp competitive kinase inhibitors
12/12/2007EP1863762A1 Indole derivatives and methods of using the same
12/12/2007EP1863572A2 New class of t cells activators and use thereof
12/12/2007EP1863571A1 Compounds for inhibiting ksp kinesin activity
12/12/2007EP1863534A1 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor
12/12/2007EP1863533A1 Combination of interleukin-6 antagonists and antiproliferative drugs
12/12/2007EP1863532A1 Anti-ctla4 antibody and indolinone combination therapy for treatment of cancer
12/12/2007EP1863530A1 Methods for damaging cells using effector functions of anti-gfra1 antibodies
12/12/2007EP1863524A1 Methods and compositions for the treatment of cancer
12/12/2007EP1863520A1 Use of interleukin 17e for the treatment of cancer
12/12/2007EP1863519A1 Monitoring and modulating hgf/hgfr activity
12/12/2007EP1863495A1 Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin
12/12/2007EP1863491A1 Pharmaceutical combination of bcr-abl and raf inhibitors
12/12/2007EP1863481A1 Methods for administering ixabepilone
12/12/2007EP1863480A1 Compounds having immunomodulator activity
12/12/2007EP1863478A2 Indoloquinone tumor radiation sensitization
12/12/2007EP1863448A2 Novel liposome compositions
12/12/2007EP1752452A9 Propane-1,3-dione derivative or its salt
12/12/2007EP1718602A4 Therapeutic and carrier molecules
12/12/2007EP1660500B1 Substituted imidazopyrimidines for the prevention and treatment of cancer
12/12/2007EP1644403B1 Cytotoxic depsipeptides
12/12/2007EP1556058B1 Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
12/12/2007EP1551824B1 Protein tyrosine kinase inhibitors
12/12/2007EP1496933A4 Use of interleukin-19 to treat ovarian cancer
12/12/2007EP1496880A4 SYNERGISTIC EFFECTS OF NUCLEAR TRANSCRIPTION FACTOR NF-kB INHIBITORS AND ANTI-NEOPLASTIC AGENTS
12/12/2007EP1474414B1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
12/12/2007EP1470120B1 N-oxyde of n-phenyl-2-pyrimidine-amine derivatives
12/12/2007EP1276738B1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
12/12/2007EP1268481B1 Kinase inhibitors as therapeutic agents
12/12/2007EP1148779B1 Expression of secreted human alpha-fetoprotein in transgenic animals
12/12/2007EP1144454B1 Modified peptides as therapeutic agents
12/12/2007EP1143943B1 USE OF p53 INHIBITORS FOR THE TREATMENT OF SIDE EFFECTS OF CANCER THERAPY
12/12/2007EP1137792B9 A recombinant vector expressing multiple costimulatory molecules and uses thereof
12/12/2007EP0932606B1 Inhibitors of prenyl transferases
12/12/2007EP0894130B1 Modulators of tnf receptor associated factor (traf), their preparation and use
12/12/2007EP0769967B1 Conjugates comprising an antitumour agent and their use
12/12/2007CN101087798A Sulfonamido-macrocycles as tie2 inhibitors
12/12/2007CN101087797A Sulfonamido-macrocycles as tie2 inhibitors
12/12/2007CN101087792A Synthetic process for preparing dual loop compound
1 ... 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 ... 2211